Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist

Ms. Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

University of Wollongong | Australia

Ms. Ebeney Whillas is a sports nutrition researcher whose work focuses on nutrition-related experiences during the transition from elite sport to post-competitive life. Her research is grounded in qualitative inquiry, addressing a critical gap in sports nutrition literature by centering the voices of former elite athletes. She is the lead author of a peer-reviewed article published in Nutrients (MDPI), which examines how entrenched sporting cultures continue to shape eating behaviours, health perceptions, and wellbeing after retirement from elite competition. Her scholarship contributes to a growing recognition that athlete nutrition support must extend beyond performance-focused phases to encompass long-term health and adjustment. Ms. Whillas’ research interests include athlete transition, sports nutrition culture, and the relationship between nutrition practices and mental wellbeing. Through her work, she provides evidence to inform more holistic, sustainable, and athlete-centered nutrition interventions across the full athletic lifespan.

Profiles: Sci Profiles | LinkedIn

Featured Publications

• Whillas, E. K., Craddock, J. C., & Lambert, K. (2025). Navigating nutrition beyond elite sport: A qualitative exploration of experiences after retirement. Nutrients, 17(24), Article 3920. https://doi.org/10.3390/nu17243920

Gabriella Gould | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist

Ms. Gabriella Gould | Medicine and Health Sciences | Research Excellence Award

Bond University | Australia

Ms. Gabriella Gould is a dedicated physiotherapist and researcher with a focused expertise in musculoskeletal and vestibular physiotherapy, emphasizing evidence-based clinical assessment and rehabilitation strategies. Her research endeavors explore the diagnostic and therapeutic applications of physiotherapy interventions, with a particular emphasis on musculoskeletal conditions such as rotator cuff tendinopathy. Ms. Gabriella Gould’s most notable contribution is her systematic review on the use of diagnostic ultrasound for assessing rotator cuff tendinopathy, published in Ultrasound in Medicine & Biology. This work rigorously synthesizes current methodologies, highlighting both the strengths and limitations of ultrasound as a clinical assessment tool, and provides clinicians with clear, evidence-based guidance for improved diagnostic accuracy. Her research approach integrates clinical insights with scientific rigor, bridging the gap between research evidence and practical physiotherapy applications. In addition to her publications, Ms. Gabriella Gould actively engages with the broader research community through professional memberships, contributing to the development of standardized assessment protocols and evidence-informed practice guidelines. Her research contributions extend to promoting patient-centered care by ensuring that diagnostic and rehabilitation strategies are both effective and accessible. By combining innovative research, systematic evidence evaluation, and a commitment to translational application, Gabriella Gould’s work not only enhances the scientific understanding of musculoskeletal assessment but also drives improvements in clinical practice, optimizing patient outcomes. Her ongoing research interests continue to focus on advancing diagnostic precision, validating therapeutic interventions, and supporting the integration of emerging technologies into physiotherapy practice, establishing her as a rising contributor to evidence-based musculoskeletal and vestibular physiotherapy research.

Profiles: ORCID | LinkedIn

Featured Publication

Gould, G., Macindoe, C., Wong, J., & Matthews, W. (2025). The use of diagnostic ultrasound for the assessment of rotator cuff tendinopathy: A systematic review. Ultrasound in Medicine & Biology.

Eduardo Vignoto Fernandes | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist

Prof. Dr. Eduardo Vignoto Fernandes | Medicine and Health Sciences | Research Excellence Award

Federal University of Jataí | Brazil

Prof. Dr. Eduardo Vignoto Fernandes, is a distinguished researcher in immunometabolism, human physiology, and applied health sciences, recognized for his multidisciplinary contributions integrating experimental pathology, human anatomy, and exercise science. With 28 Scopus-indexed publications, 119 citations, and an h-index of 5, his research advances understanding of metabolic, genetic, and physiological adaptations in healthy individuals and those with clinical or lifestyle-related conditions, including people living with HIV/AIDS. Fernandes has produced influential studies covering immunometabolism responses, exercise physiology, body composition, sports nutrition, metabolic syndrome, cancer immunopathology, and antiretroviral therapy effectiveness. His scientific output includes peer-reviewed articles, systematic reviews, and collaborative investigations published in respected journals such as Metabolites, Geriatrics, Sports, Current HIV Research, Molecular Biology Reports, and Discover Public Health. Fernandes leads and collaborates on research projects exploring exercise prescription, photo biomodulation, osteopathic interventions, muscle damage biomarkers, and functional health indicators such as handgrip strength. His expertise also extends to educational research on human anatomy, including remote versus in-person instruction and academic performance in health-science students. Through public health outreach initiatives, he contributes to community wellness by developing structured exercise programs and participating in One Health–aligned interdisciplinary actions. Supported by competitive funding from major Brazilian agencies, he conducts R&D focused on immunometabolism health, functional performance, and applied health interventions. His growing citation base, broad research themes, and sustained collaborations underscore his scientific relevance and expanding impact across exercise science, pathology, and applied health research.

Profiles: Scopus | Google Scholar | ORCID | ResearchGate

Featured Publications

1. De Rossi, T., Lozovoy, M. A. B., da Silva, R. V., Fernandes, E. V., Geraldino, T. H., & others. (2011). Interações entre Candida albicans e hospedeiro. Semina: Ciências Biológicas e da Saúde, 32(1), 15–28.

2. Weber, M. G., Dias, S. S., de Angelis, T. R., Fernandes, E. V., Bernardes, A. G., & others. (2021). The use of BCAA to decrease delayed-onset muscle soreness after a single bout of exercise: A systematic review and meta-analysis. Amino Acids, 53(11), 1663–1678.

3. Romanin, P., Palermo, R. L., Cavalini, J. F., Favaro, L. S., De Paula-Petroli, S. B., Fernandes, E. V., & others. (2019). Multidrug- and extensively drug-resistant Acinetobacter baumannii in a tertiary hospital from Brazil: The importance of carbapenemase encoding genes and related resistance mechanisms. Microbial Drug Resistance, 25(9), 1365–1373.

4. Khan, S. A., Venancio, E. J., Ono, M. A., Fernandes, E. V., Hirooka, E. Y., Shimizu, C. F., & others. (2019). Effects of subcutaneous ochratoxin-A exposure on immune system of broiler chicks. Toxins, 11(5), 264.

5. Vitorino, R. W. S., Fornaziero, C. C., & Fernandes, E. V. (2020). Evaluation of performance and perception of learning in teaching human anatomy: Traditional method vs constructivist method. International Journal of Morphology, 38(1), 74–77.

Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Izmir Katip Çelebi University Atatürk Training and Research Hospital | Turkey

Dr. Tuncay Kırış, an Associate Professor at İzmir Kâtip Çelebi University, Izmir, Turkey, is a distinguished cardiology researcher recognized for his extensive contributions to cardiovascular medicine, particularly in the fields of cardiovascular risk prediction, interventional cardiology, acute coronary syndromes, and cardiac biomarkers. His research has provided valuable insights into myocardial infarction, pulmonary embolism, renal complications following cardiac interventions, and the prognostic implications of biochemical and hematological markers in predicting patient outcomes. Dr. Tuncay Kırış has authored 83 peer-reviewed publications in prestigious international journals indexed in SCI and SCI-Expanded, including Angiology, BMC Cardiovascular Disorders, The Anatolian Journal of Cardiology, Clinical and Experimental Hypertension, Herz, and Acta Radiologica. His works have received 591 citations from 544 documents, with an h-index of 15, according to Scopus (Author ID: 55321350600), reflecting his strong academic impact. His studies emphasize innovative predictive and prognostic modeling approaches, such as exploring the fibrinogen-to-albumin ratio, red cell distribution width, and lymphocyte-to-monocyte ratio as novel indicators of adverse cardiovascular events and renal complications. Beyond his research, he has supervised postgraduate theses on cardiovascular risk assessment, contributed to collaborative projects in clinical and translational cardiology, and serves as Editor of the Ege Klinikleri Tıp Dergisi. As an active reviewer for several international cardiology journals, Dr. Tuncay Kırış continues to advance evidence-based cardiology through data-driven research, bridging clinical practice with innovation to improve patient outcomes and global cardiovascular health.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  • Yildirim, S. E., Yildirim, T., Kırış, T., & Avci, E. (2025, October). Prognostic value of the NAPLES score and serum uric acid in chronic coronary syndrome: Evidence from time-dependent ROC and time-varying hazard ratio analyses. Journal of Clinical Medicine, 14(20), 7416. https://doi.org/10.3390/jcm14207416

  • Tiryaki, M. M., Yılmaz, C., Ince, H. S., Karaca, B., Kayaalti Esin, F., & Kırış, T. (2025, September). Neutrophil percentage-to-albumin ratio as a predictor of in-hospital mortality in infective endocarditis. Biomarkers in Medicine, 19(17), 1–8. https://doi.org/10.1080/17520363.2025.2562554

  • Akkan, G., Kırış, T., Esin, F., & Karaca, M. (2025, May). Evaluation of mortality and hospitalization due to decompensated heart failure and appropriate shocks in reduced ejection fraction in patients with an implantable cardioverter–defibrillator according to a novel tissue Doppler echocardiographic method. Journal of Clinical Medicine, 14(9), 3226. https://doi.org/10.3390/jcm14093226

  • Esin, F., Bozkurt, H., Palac, B., Akar, B., Kırış, T., Özdemir, E., & Karaca, M. (2025, February). The impact of pleural effusion on long-term mortality in patients undergoing transcatheter aortic valve implantation. Journal of Clinical Medicine, 14(5), 1596. https://doi.org/10.3390/jcm14051596

  • Usta, A., Sancakli Usta, C., Lafci, D., Kırış, T., & Avci, E. (2024, December). Contrast induced nephropathy in women with infertility undergoing hysterosalpingography. Reproductive Biology and Endocrinology, 22(1). https://doi.org/10.1186/s12958-024-01334-3

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479

Sahar Issa | Health Professions | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Sahar Issa | Health Professions | Best Researcher Award

Faculty of medicine, Alexandria University | Egypt

Dr. Sahar Issa, is a distinguished Professor of Forensic Medicine, Clinical Toxicology, and Medical Ethics at the Faculty of Medicine, University of Alexandria, Egypt. She earned her Ph.D. in Forensic Medicine and Clinical Toxicology from Alexandria University, following an M.Sc. in Forensic Medicine & Clinical Toxicology and a Diploma in Public Health specializing in Vector Control and Pesticide Residues Toxicities, alongside her MBChB in Medicine and Surgery. Over her extensive academic career, Dr. Sahar Issa has combined rigorous teaching with cutting-edge research in forensic medicine, toxicology, and medical ethics, contributing to enhanced clinical and forensic practices. Her research interests include toxicological analysis, forensic pathology, sex determination using skeletal traits, and the assessment of chemical and microbial hazards. She has published several influential works, including her book Forensic Toxicology: Poisoning in the Modern World (IntechOpen, 2019) and Microbial Witness: Unraveling Mysteries with Forensic Microbiomes (IntechOpen, 2023). Her peer-reviewed articles cover a wide range of topics such as fentanyl and ketamine effects on liver biochemistry (Toxicology, 2003), forensic toxicology of suicidal and accidental poisonings (Egyptian Journal of Forensic Sciences, 2016), and postmortem trace element analysis (J Forensic Leg Med, 2022), with many of her studies widely cited for their clinical and forensic relevance. Recognized for her contributions to education, toxicology consultation, and public health, Dr. Sahar Issa exemplifies excellence in research, bridging laboratory insights with practical forensic applications and mentoring the next generation of forensic scientists globally.

Profile: Google Scholar | ORCID | LinkedIn

Featured Publications

Hafez, E. M., Issa, S. Y., Ai-Mazroua, M. K., Ibrahim, K. T., & Rahman, S. M. A. (2016). The neonicotinoid insecticide imidacloprid: A male reproductive system toxicity inducer-human and experimental study.

Hafez, M. E., Issa, Y. S., & Abdel Rahman, M. S. (2015). Parenchymatous toxicity of tramadol: Histopathological and biochemical study. Journal of Alcohol and Drug Dependence, 3(5), 225.

Issa, S. Y., Khanfour, A. A., & Kharoshah, M. (2016). A model for stature estimation and sex prediction using percutaneous ulnar and radial lengths in autopsied adult Egyptians. Egyptian Journal of Forensic Sciences, 6(2), 84–89.

Ibrahim, S. Y. (2016). Determination of heavy metals and other toxic ingredients in henna (Lawsonia inermis). Journal of Environmental & Analytical Toxicology, 6(3), 9.

Cebolla, S. G., [et al.]. (2018). Fully automated forensic routine dried blood spot screening for workplace testing. Journal of Analytical Toxicology, 43(2), 1–11.

Issa, S. Y., Hafez, E. M., El-Banna, A. S., Abdel Rahman, S. M., AlMazroua, M. K., … [et al.]. (2018). Baclofen systemic toxicity: Experimental histopathological and biochemical study. Human & Experimental Toxicology, 37(4), 431–441.

Zagloul, N. M., Farghaly, R. M., ELKhatib, H., Issa, S. Y., & El-Zoghby, S. M. (2022). Technology facilitated sexual violence: A comparative study between working and non-working females in Egypt before and during the COVID-19 pandemic. Egyptian Journal of Forensic Sciences, 12(1), 21.

Alalawi, S., Issa, S. T., Takshe, A. A., & ElBarazi, I. (2022). A review of the environmental implications of the COVID-19 pandemic in the United Arab Emirates. Environmental Challenges, 8, 100561.

Eddine, N. N., Noisel, N., Dieme, D., Asmar, M. K., Issa, S. T., & Bouchard, M. (2022). Multi-matrix biomonitoring approach to assess exposure to metals and trace elements in the Lebanese population and associations with drinking water consumption. Environmental Research, 214, 113982.

Long Chang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Yan Bai | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Yan Bai | Medicine and Health Sciences | Best Researcher Award

Yunnan University | China

Dr. Yan Bai is a highly accomplished postdoctoral researcher at the State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan and the Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, China. She earned her PhD in Cell Biology from Yunnan University, MSc in Pharmacology from the Chinese PLA Medical Academy, and BSc in Pharmacy from Dali University, establishing a strong interdisciplinary foundation spanning pharmacology, microbiology, and cellular biology. Prior to her current role, she conducted research at the Chinese PLA General Hospital, focusing on combination therapies against multidrug-resistant bacteria. Her research primarily investigates mitochondrial homeostasis, tumor biology, and the molecular mechanisms underlying mitochondrial genetic diseases, with particular attention to mitochondria-associated condensates (MATOs) as regulators of protein translation and mitochondrial integrity. Dr. Yan Bai has led and contributed to several major research projects, including grants from the National Natural Science Foundation of China, the National Basic Research Program, and Yunnan Province Science and Technology initiatives. Her work has resulted in high-impact publications in journals such as Nature Aging (2025), Sci China Life Sci (2025), EMBO J (2024), and Biophys Rep (2024). According to Scopus, she has authored 10 publications, cited 177 times across 169 documents, with an h-index of 6, demonstrating both productivity and influence in her field. Through her interdisciplinary collaborations, innovative experimental approaches, and groundbreaking findings on mitochondrial regulation and aging, Dr. Yan Bai has made significant contributions to biomedical science, advancing understanding of mitochondrial biology, disease mechanisms, and translational biomedical applications.

Profile: Scopus

Featured Publications

Bai, Y., Ma, T., Zhao, S., Li, S., Wang, X., Li, J., Sun, W., Yang, Y., Liu, F., Shan, Q., Qin, Z., Liu, N., Zhang, J., Tian, F., Duan, M., Chen, S., Lai, F., Chen, Q., Wu, X., & Yang, C. (2025). Mitochondria-associated condensates maintain mitochondrial homeostasis and promote lifespan. Nature Aging.

Hao, Q., Bai, Y., Guan, R., Dong, R., Bai, W., Hamdy, H., Wang, L., Meng, M., Sun, Y., Shen, J., & Sun, J. (2025). VPS35/Retromer-dependent MT1-MMP regulation confers melanoma metastasis. Science China Life Sciences, 68(7), 1996–2009.

Hao, Q., Dong, R., Bai, W., Chang, D., Yao, X., Zhang, Y., Xu, H., Li, H., Kui, X., Wang, F., Wang, Y., Wang, C., Lei, Y., Chen, Y., Shen, J., Sang, L., Bai, Y., & Sun, J. (2024). Screening for metastasis-related genes in mouse melanoma cells through sequential tail vein injection. Biophysical Reports, 10(1), 15–21.

Liu, F., Li, T., Gong, H., Tian, F., Bai, Y., Wang, H., Yang, C., Li, Y., Guo, F., Liu, S., & Chen, Q. (2024). Structural insights into the molecular effects of the anthelmintics monepantel and betaine on the Caenorhabditis elegans acetylcholine receptor ACR-23. EMBO Journal, 43(17), 3787–3806.

Wang, T., Zhou, X., Bai, Y., Zhang, L., Li, L., & Wu, C. (2018). Antiepileptic effect of uridine may be caused by regulating dopamine release and receptor expression in corpus striatum. Brain Research, 1688, 47–53.

Bai, Y., Liu, B., Wang, T., Cai, Y., Liang, B., Wang, R., Liu, Y., & Wang, J. (2015). In vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 59(3), 1466–1471.

Liu, B., Bai, Y., Liu, Y., Di, X., Zhang, X., Wang, R., & Wang, J. (2015). In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii. Journal of Chemotherapy, 27(5), 271–276.

Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

University Hospital Basel | Switzerland

Dr. Andrej Sirek is a dedicated Pathology Resident at the University Hospital Basel, Institute of Medical Genetics and Pathology, where he is actively shaping his career at the intersection of clinical diagnostics and medical research. With his educational foundation built in leading European institutions, Dr. Andrej Sirek has developed a strong grounding in medical genetics, histopathology, and laboratory sciences, which now supports his dual role as both clinician and researcher. His residency provides him with exposure to complex pathology cases while also allowing him to engage in research that seeks to bridge genetic profiling and diagnostic pathology, with the long-term aim of contributing to precision medicine and early disease detection. Currently, he has completed one research project and is progressing with another, both expected to yield indexed publications in the near future. Despite being at an early stage of his academic career, his commitment to innovation in pathology has already been recognized with a nomination for the Best Researcher Award. He maintains active membership in several professional organizations, including SGPATH, ÖGPATH, SGZ, and ESP, which strengthens his global collaborations and engagement with the wider pathology community. While he has yet to publish peer-reviewed articles, his ongoing research demonstrates his potential to make impactful contributions to the field. His academic and professional journey underscores the promise of a new generation of clinician-scientists who integrate advanced diagnostic techniques with research innovation to improve patient care. Dr. Andrej Sirek’s trajectory highlights his dedication, scholarly potential, and commitment to excellence in pathology and medical genetics.

Profile: ORCID

Featured Publications

Dr. Andrej Sirek has contributed to impactful research in pathology, focusing on diagnostic innovations, tumor biology, and clinicopathological correlations. Key recent publications include:

Sirek, A., Hench, I. B., Hench, J., Alborelli, I., Gross, M. W., Jakscha, J., Schaller, P., Nagel, G., Baumhoer, D., & Tzankov, A. (2025). Recurrent clonal radiotherapy-associated fibroepithelial polyp of the pharynx: Do low grade radiogenic stromal tumours exist? Case report.

Sobottka, B., Vetter, V., Banaei-Esfahani, A., Nowak, M., Lorch, A., Sirek, A., Mertz, K. D., Brunelli, M., Berthold, D., de Leval, L., et al. (2024). Immune phenotype-genotype associations in primary clear cell renal cell carcinoma and matched metastatic tissue.